W
WAVEMAN · COMPANY
BAH · Booz Allen Hamilton Holding Corp
> Ask across nine datasets ⌘K
LIVE
TEAM-0.32% 13F +439META+3.01% 13F +2,694RCG-2.04% CLUSTERUTHR-4.03% 13F +425CRWV+4.49% 13F +693CRM+2.92% 13F +1,018CVNA-0.98% 13F +794TPL-0.71% 13F +444NET+4.32% 13F +710MSTR+17.56% 13F +526DELL+4.91% 13F +1,203CRWD+5.68% 13F +1,382ANET+1.22% 13F +1,323COIN+10.14% 13F +475TEAM-0.32% 13F +439META+3.01% 13F +2,694RCG-2.04% CLUSTERUTHR-4.03% 13F +425CRWV+4.49% 13F +693CRM+2.92% 13F +1,018CVNA-0.98% 13F +794TPL-0.71% 13F +444NET+4.32% 13F +710MSTR+17.56% 13F +526DELL+4.91% 13F +1,203CRWD+5.68% 13F +1,382ANET+1.22% 13F +1,323COIN+10.14% 13F +475
← ALL COMPANIES

BAH

Booz Allen Hamilton Holding Corp
PHARMA & BIOTECH · SERVICES-MANAGEMENT CONSULTING SERVICES · CIK 0001443646
FORM 144 · 1☆ WATCH
INSIDER NET · 180D
-$36.5K
open-market buys minus sells, Form 4 codes P and S
INSIDER BUYERS · 180D
0
CONGRESS BUYERS · 1Y
0
FUNDS ADDED · QTR
286
13F, latest reported quarter
REVENUE GROWTH
-6.4%
XBRL, annual
NET MARGIN
7.6%
SEVEN FACTS, RANKED AGAINST THE SECTOR · RANK IS NOT A FORECAST
INSIDERS
net -$36.5K over 180 days
-$36.5K over 90 days
more than 60% of Pharma & Biotech
CONGRESS
no member of Congress has reported trading it
FUNDS
286 funds added or opened last quarter
more than 93% of Pharma & Biotech
REVENUE
-6.4% year over year
below 67% of Pharma & Biotech
MARGIN
7.6% net margin
more than 77% of Pharma & Biotech
BUYBACKS
$72.0M repurchased, FY to 2026-06-30
more than 62% of Pharma & Biotech
SHORT
6.9% of shares outstanding short · 3.0 days to cover · settled 2026-07-31
more than 65% of Pharma & Biotech
THE SITUATION · EVERY LINE IS ONE RULE OVER ONE DATASET
286 funds added or opened positions in the latest 13F quarter, of 559 holders.
Federal contracts worth $398.7M were awarded in the last 180 days.
The year, with the filings on it
Total return indexed to 100 over the last 12 months · every marker is a federal filing, placed at its date — hover any marker for the detail
TOTAL 12M RETURN -31.9%
-31.9%12M
-45%-30%-15%+0%2025-092025-102025-122026-032026-052026-072026-09 2025-10-30 · ROZANSKI HORACIO bought $2.0M2026-08-13 · Metzfield Dennis sold $36.5K2026-02-26 · Metzfield Dennis sold $27.5K2026-08-13 · Metzfield Dennis filed to sell $36.5K
INSIDER BUYINSIDER SELLFORM 144
INDEXED RETURN, DIVIDEND-ADJUSTED — NOT A PRICE CHART · LARGE TRADES DRAWN FIRST WHEN A NAME FILES HEAVILY
Live price
Daily candles from TradingView, on their licence — no filings are marked on this one
WHY THIS NAME IS ON THE DESK
Insiders have filed to sell — before selling.
The record shows a net $36.5K sold by insiders over 180 days, 286 funds added last quarter, $36.5K in planned Form 144 sales. Every figure is a federal filing, dated the day it became public.
Backtest this pattern Open the screener
Same sector, ranked by filing activity
Sector from the SEC's own SIC classification
UTHRCPIXMRNAREGNLLYALNYELFCITRMDGLDNAVRTXNUVL
Insider transactions
Form 4 purchases and sales (codes P and S) — grants, option exercises and preferred conversions excluded

Over the last 180 days, Booz Allen Hamilton Holding Corp insiders sold a net $36.5K of stock across 69 Form 4 purchases and sales, with 0 insider(s) buying. Source: SEC Form 4 filings, as of 2026-09-05.

INSIDER
FILED
SHARES
VALUE
Metzfield Dennis
VP, PAO & Controller
SELL
2026-08-13
469.0
$36.5K
Metzfield Dennis
VP, PAO & Controller
SELL
2026-02-26
350.0
$27.5K
ROZANSKI HORACIO
President and CEO
BUY
2025-10-30
23,800.0
$2.0M
AMBLE JOAN LORDI
Director
BUY
2025-02-05
930.0
$121.7K
AMBLE JOAN LORDI
Director
BUY
2024-12-06
690.0
$100.5K
69 TRANSACTIONS ON RECORD

Showing the most recent few. Create a free account to see 64 more transactions on record, the cross-source screener and CSV export. We store only your email address, and there is no password to create.

Institutional holders
13F · holdings as of the latest quarter funds have reported
BlackRock, Inc.
13,266,423.0 sh
$804.9M
VANGUARD PORTFOLIO MANAGEMENT LLC
7,358,547.0 sh
$446.4M
PRIMECAP MANAGEMENT CO/CA/
6,397,644.0 sh
$388.1M
VANGUARD CAPITAL MANAGEMENT LLC
5,405,478.0 sh
$328.0M
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
3,993,220.0 sh
$242.3M
SCHEDULE 13D/G
No 5%+ ownership filings
Nobody has crossed 5% with a filing obligation. Absence is a fact here, not missing data.
Planned sales · Form 144
Filed before the sale — intent, not a trade
Metzfield Dennis
FILED 2026-08-13
$36.5K
Fund concentration
N-PORT · funds ranked by how much of THEMSELVES they put in this stock — the conviction number 13F cannot show
iShares Cybersecurity and Tech ETF
$28.5M POSITION · AS OF 2026-04-30
3.8%
Monarch Dividend Plus Index ETF
$2.0M POSITION · AS OF 2026-02-28
3.4%
Baron SMID Cap ETF
$686.2K POSITION · AS OF 2026-03-31
2.6%
Calamos Phineus Long/Short Fund
$28.0M POSITION · AS OF 2026-04-30
2.5%
GMO Small Cap Quality Fund
$14.6M POSITION · AS OF 2026-02-28
2.1%
DIAMOND HILL LONG SHORT FUND
$46.4M POSITION · AS OF 2026-03-31
2.1%
SEC N-PORT, MONTHLY WITH A ~60-DAY PUBLIC LAG · FUNDS ≥ $10M · % = SHARE OF THE FUND'S OWN BOOK
Government contracts
USASpending.gov · total award ceilings over the contract's life, including awards won through subsidiaries — not annual revenue
Department Of Veterans Affairs
TRANSFORMATION TWENTY-ONE TOTAL TECHNOLOGY NEXT GENERATION (T4NG) TASK ORDER - BENEFITS INTEGRATED D · 2021-05-17
$1.4B
General Services Administration
TASK ORDER AWARD · 2022-09-06
$1.2B
General Services Administration
THE PURPOSE OF THIS EFFORT IS TO ACQUIRE CONTRACTOR SERVICES TO PROVIDE REAL-TIME, COMPREHENSIVE THR · 2020-06-26
$1.1B
Department Of Veterans Affairs
NEW TO - EHRM PMO IO SUPPORT · 2022-09-28
$859.7M
Department Of Veterans Affairs
IGF::OT::IGF INFORMATION TECHNOLOGY OPERATIONS AND SERVICES TRANSFORMATION SUPPORT SERVICES · 2019-05-17
$809.8M
Department Of Veterans Affairs
THE CONTRACTOR SHALL PROVIDE SHIPPABLE PRODUCTS, OPERATIONS SUPPORT, AND SECURITY COMPLIANCE FOR THE · 2021-09-30
$713.8M
FEDERAL AWARDS ≥ $25M IN THE LAST 90 DAYS · MATCHED VIA SAM.GOV PARENT REGISTRY
Executive pay vs shareholder return · Horacio D. Rozanski
DEF 14A pay-versus-performance disclosure · both the headline pay and the SEC's mark-to-market figure, beside the return the company delivered and the return of the peer group it chose itself
FY
CEO TOTAL
ACTUALLY PAID
OTHER NEOs AVG
TSR
PEER TSR
2025
$13.8M
$3.3M
$3.1M
+6%
-8%
2024
$14.0M
-$2.7M
$5.9M
+66%
+98%
2023
$15.6M
$48.2M
$3.7M
+132%
+92%
2022
$12.2M
$16.0M
$3.7M
+42%
+52%
2021
$11.9M
$9.9M
$3.1M
+32%
+81%
TAGGED BY THE COMPANY UNDER SEC ITEM 402(v) · RETURN IS CUMULATIVE FROM THE START OF THE DISCLOSURE PERIOD · GREEN WHERE THE COMPANY BEAT ITS OWN PEER GROUP
Fundamentals
Annual figures from XBRL filings · pick a past date to see them exactly as the market knew them then — restatements and all
2026-032025-032024-032023-03
REVENUE$11.2B$12.0B$10.7B$9.3B
OPERATING INCOME$1.0B$1.4B$1.0B$447.0M
NET INCOME$850.5M$935.0M$605.7M$271.2M
EPS (DILUTED)6.907.254.592.03
OPERATING CASH FLOW$1.0B$1.0B$259.0M$603.0M
CASH$728.0M$885.0M$554.0M$404.9M
LONG-TERM DEBT$3.9B$3.9B$3.4B$2.8B
BUYBACKS$598.0M$812.0M$404.0M$224.0M
DIVIDENDS PAID$276.0M$268.0M$254.0M$236.0M
SEC XBRL · FISCAL-YEAR PERIODS · AS KNOWN ON 2026-09-05 · NOBODY ELSE SHOWS FUNDAMENTALS AS OF A PAST DATE
W WAVEMAN

Public filings, honestly analyzed. Official US government sources in one desk — every figure carries the date it was filed, and the methodology is published, backtest included.

SEC FORM 4FORM 13F 13D/GFORM 144XBRL STOCK ACTCONTRACTSFEC CFPBNRC
PRODUCT
DeskBacktester CompaniesAccount
SUPPORT
FAQMethodology Contact
LEGAL
TermsPrivacy Accessibility
© 2026 WAVEMAN · SOURCE: SEC EDGAR & OFFICIAL GOVERNMENT DATA · NOT INVESTMENT ADVICE · CHART BY TRADINGVIEW · UPDATED 2026-09-05 ALL SYSTEMS LIVE FOR MACHINES →